Pancreatic cancer has a notoriously low survival rate, with just 25% of patients living for a year or more after their ...

Pancreatic cancer is one of the most aggressive cancers and has one of the lowest survival rates—only 10% after five years. One of the factors contributing to its aggressiveness is its tumor ...

Future prospective studies and clinical trials are necessary to determine whether vitamin D supplementation can improve survival outcomes in pancreatic cancer patients,” the researchers wrote.

A laboratory on Long Island has found a breakthrough in the fight against pancreatic cancer that can “intercept” its spread.

In this video, Alan Dow, MD, MSHA, FACP, discusses evolving cancer screening guidelines and the controversies surrounding some of them. The first screening update involved pancreatic cancer.

City of Hope researchers demonstrate proof of concept for a novel targeted therapy for pancreatic cancer, exploiting transcription-replication conflicts to combat treatment resistance.

Pancreatic cancer is one of the most aggressive cancers and has one of the lowest survival rates—only 10% after five ...

A new study focused on transcription-replication conflicts, which occur when mechanisms responsible for gene expression and genome duplication collide.

Bloomston emphasized the importance of awareness regarding conditions linked to pancreatic cancer, such as the BRCA mutation, ...

Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S.

Pancreatic cancer remains one of the most deadly malignancies, with nearly 52,000 deaths expected this year.  With limited therapeutic advances made i | Cancer ...

The use of ablative radiation therapy (A-RT) led to promising overall survival and effective local tumor control in patients ...